Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment (Q39532988)

12 September 2017

title

Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment (English)

1 reference

12 September 2017

Dongyun Ouyang

1

1 reference

12 September 2017

Yanting Zhang

2

1 reference

12 September 2017

Lihui Xu

3

1 reference

12 September 2017

Jingjing Li

4

1 reference

12 September 2017

Qingbing Zha

5

1 reference

12 September 2017

Xianhui He

6

1 reference

12 September 2017

publication date

1 June 2011

1 reference

Acta Biochimica et Biophysica Sinica

12 September 2017

published in

1 reference

12 September 2017

volume

43

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

487-495

1 reference

Current management of metastatic melanoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Epigenetics and cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Histone deacetylase inhibitors as anti-neoplastic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Coping with stress: eIF2 kinases and translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Cisplatin induces a persistent activation of JNK that is related to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Regulation of Stat3 activation by MEK kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Opposite regulation of myc and p21waf1 transcription by STAT3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMR032

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMR032

1 reference

release_yz3zztskgvglpgjipqd2o4sbl4

12 September 2017

Fatcat ID

0 references

1 reference